Nanoencapsulated Delivery of Genes

ANP's Nanoencapsulation platform technology is also ideal for delivery of gene-based therapies for personalized medicine, particularly for efficiently delivering Oligodeoxynucleotides(ODN)/DNA/mRNA or peptide based vaccines/neo-antigens for cancer or infectious disease therapies.

Advantages:

• Significantly improved delivery efficiency of ODN/DNA/mRNA payloads compared to other delivery methods/platform systems.

• Superb in vivo animal efficacy data across a multitude of different cargo types

• Custom Formulations to fine tune specific drug attributes (targeting, PK/PD profile, safety, etc.)